Stomper P C, Herman S, Klippenstein D L, Winston J S, Edge S B, Arredondo M A, Mazurchuk R V, Blumenson L E
Department of Diagnostic Radiology, Roswell Park Cancer Institute, State University at New York (SUNY) at Buffalo 14263, USA.
Radiology. 1995 Nov;197(2):387-95. doi: 10.1148/radiology.197.2.7480682.
To prospectively correlate dynamic contrast enhancement at magnetic resonance (MR) imaging with mammographic and pathologic features of suspect breast lesions.
Forty-nine patients with 51 breast lesions underwent gadolinium-enhanced spoiled gradient-recalled echo (SPGR) MR imaging at 1.5 T, as well as excisional biopsy or cyst aspiration.
Twenty-two of 22 (100%) invasive carcinomas 8 mm or more in diameter, including three (12%) not evident on dense mammograms, enhanced 2.0 or more times the unenhanced intensity. One of three predominantly ductal carcinomas in situ and 10 of 26 (38%) benign lesions enhanced 2.0 or more times. Time-intensity curves were not statistically significantly different among enhancing carcinomas, fibroadenomas, or other benign lesions and showed no statistically significant correlations with pathologic size, nodal status, or hormone receptor status of invasive carcinomas.
MR imaging enhancement of 2.0 or more times had high sensitivity (100%) for invasive carcinomas 8 mm or more in diameter, with moderate specificity (65%). Time-intensity curves showed no significant difference between enhancement of benign and malignant lesions.
前瞻性地将磁共振(MR)成像的动态对比增强与可疑乳腺病变的乳腺X线摄影和病理特征相关联。
49例患有51个乳腺病变的患者接受了1.5T钆增强扰相梯度回波(SPGR)MR成像,以及切除活检或囊肿抽吸。
22个直径8毫米或更大的浸润性癌中的22个(100%),包括3个(12%)在致密乳腺X线摄影上不明显的,增强至未增强强度的2.0倍或更高。3个主要为导管原位癌中的1个以及26个(38%)良性病变中的10个增强至2.0倍或更高。增强的癌、纤维腺瘤或其他良性病变之间的时间-强度曲线在统计学上无显著差异,并且与浸润性癌的病理大小、淋巴结状态或激素受体状态无统计学上的显著相关性。
增强2.0倍或更高对直径8毫米或更大的浸润性癌具有高敏感性(100%),特异性中等(65%)。良性和恶性病变增强之间的时间-强度曲线无显著差异。